Please visit: https://www.fortunebusinessinsights.com/industry-reports/immunodiagnostics-market-100444
The Global Immunodiagnostics Market held USD 13.91 billion in 2019 and is predicted to reach USD 31.46 million by 2030 with a CAGR of 7.7% from 2020-2030.Immunodiagnostics is a method to diagnose the disease on the basis of antigen-antibody reactions.
It is a primary means for diagnosing infectious disease, chronic diseases such as cancer & cardiovascular diseases, autoimmunity diseases, and among others.
Also, the increase in incidence and prevalence of infectious diseases and growing awareness about immunodiagnostics has further increased the immunodiagnostics market size.Access Full Description of this report at:- https://www.nextmsc.com/report/immunodiagnostics-market Top Companies: Johnson & Johnson, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott Laboratories, Immunodiagnostic Systems Holdings Plc, DiaSorinS.p.A, Siemens AG, Sysmex Corporation, Danaher Corporation, Arkray, Inc and others.The immunodiagnostics market is segmented on the basis of product, technology, downstream, and geography.
On the basis of downstream, the market is classified into clinical laboratories, hospitals, academic and research centers, pharmaceutical and biotechnology industry, and others.
Geographic breakdown and analysis of each of the aforesaid segments include regions comprising North America, Europe, Asia-Pacific, and ROW.Request free sample copy of this report at:- https://www.nextmsc.com/Immunodiagnostics-Market/request-sample North America region holds the highest immunodiagnostics market share in immunodiagnostics market and is anticipated to hold the highest market share during the forecast period.
This is attributable to the factors including demand for immunodiagnostics tests, increasing geriatric population, the high prevalence of chronic and infectious diseases, and high consumer awareness.
According to the report, the market value was USD 52.54 billion in 2019.
Its other highlights include:In-depth analysis of the key factors driving and restraining the market growth;A comprehensive study of all segments of the market;Identification of upcoming market opportunities; andA detailed evaluation of the impact of the changes in the regional and competitive dynamics on the market.The global rocket and missile market size is projected to reach USD 71.79 billion by 2027, exhibiting a CAGR of 4.52% during the forecast period.
Industry Developments:March 2020: Raytheon Company secured a USD 1 billion-worth agreement to buy propulsion systems for their standard missile products from Aerojet Rocketdyne.
The agreement will span five years and is focused on optimizing supply chain dynamics between the two companies.April 2020: The US Army awarded a contract of the estimated value of $6.07 billion to Lockheed Martin to produce and deliver Patriot Advanced Capability-3 (PAC-3) Missile Segment Enhancement interceptors over three years till 2023.
This will bolster the US’s position as a major supplier of missile interceptors among other leading world economies.One of the prominent factors supporting the growth of this market in North America is the consistently high levels of military spending in the US.
In 2019, the region’s market size was at USD 15.03 billion.Asia Pacific is expected to exhibit notable growth in the market owing to the rising uptake of multiple independent re-entry vehicles (MIRV) by the Chinese army.